Full Name
TOH HAN CHONG
Variants
Toh, H.C.
Toh, T.H.C.H.C.
 
 
 
Email
gmsthc@nus.edu.sg
 

Publications

Results 1-6 of 6 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
12010AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)Huynh, H ; Ngo, V.C.; Soo, K.C. ; Koong, H.N. ; Poon, D.; Choo, S.P.; Toh, H.C. ; Thng, C.H.; Chow, P.; Ong, H.S. ; Chung, A.; Goh, B.C. ; Smith, P.D.
22008Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinomaHuynh, H. ; Yu, K.; Wu, J.; Lee, M.H.; Hor, H.; Soo, K.C. ; Toh, H.C. ; Tan, P. ; Salto-Tellez, M. ; Chow, P.K.H. ; Lee, C.K.; Soong, R. ; Goh, B.C. ; Lee, H.S. ; Somani, A.; Tan, P.H. ; Palanisamy, N.; Kalpana, R.
31-Sep-2009Expression of EBV latent antigens, mammalian target of rapamycin, and tumor suppression genes in EBV-positive smooth muscle tumors: Clinical and therapeutic implicationsOng, K.W.; Teo, M.; Lee, V. ; Ong, D.; Lee, A.; Chieh, S.T.; Vathsala, A. ; Toh, H.C. 
418-Jul-2013Identification of Serum Monocyte Chemoattractant Protein-1 and Prolactin as Potential Tumor Markers in Hepatocellular CarcinomaWang, W.-W.; Ang, S.F.; Kumar, R.; Heah, C.; Utama, A.; Tania, N.P.; Li, H.; Tan, S.H.; Poo, D.; Choo, S.P.; Chow, W.C.; Tan, C.K.; Toh, H.C. 
5Dec-2021Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinomaNguyen, Phuong HD; Ma, Siming ; Phua, Cheryl ZJ; Kaya, Neslihan A; Lai, Hannah LH; Lim, Chun Jye; Lim, Jia Qi; Wasser, Martin ; Lai, Liyun; Tam, Wai Leong ; Lim, Tony KH; Wan, Wei Keat ; Loh, Tracy; Leow, Wei Qiang ; Pang, Yin Huei ; Chan, Chung Yip ; Lee, Ser Yee ; Cheow, Peng Chung ; Toh, Han Chong ; Ginhoux, Florent ; Iyer, Shridhar ; Kow, Alfred WC; Young Dan, Yock ; Chung, Alexander ; Goh, Brian KP ; Albani, Salvatore ; Chow, Pierce KH ; Zhai, Weiwei; Chew, Valerie 
6Jun-2012Personalised medicine in nasopharyngeal cancerToh, T.H.C.H.C. ; Ha, H.T.C.T.C. ; Wee, J.